1. Canada Stocks

  2. •

    Consumer Cyclical

  3. •

    Packaging & Containers
Winpak Ltd.

Winpak Ltd.

WIPKF
Winpak Ltd.US flagOther OTC
29.35
USD
+0.04
- -
1.72BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
11
12.1
12.26
12.65
13.64
13.69
13.44
13.12
15.42
18.17
17.56
17.78
18.44
13.91
Basic EPS, GAAP
1.1
1.21
1.53
1.61
1.84
1.68
1.77
1.64
1.6
1.97
2.28
2.35
2.25
1.62
Free Cash Flow per Basic Share
0.55
0.75
1.57
0.82
1.33
0.9
1.57
1.61
0.75
0.43
2.34
0.91
1.65
1.05
Dividend per Share
0.12
1.01
1.23
0.09
0.09
0.09
0.09
0.09
2.55
0.09
0.09
0.1
2.29
0.11
Book Value per Share
8.88
9
9.32
10.86
12.58
14.19
15.91
17.43
16.62
18.52
20.75
19.68
21.09
21.84
Tangible Book Value per Share
8.89
9.02
9.36
10.97
12.75
14.36
15.82
17.4
16.63
18.55
20.8
19.72
21.19
21.93
Basic Weighted Avg Shares
65
65
65
65
65
65
65
65
65
65
65
64
61
60
Sales/Revenue/Turnover
715
787
797
823
887
890
874
852
1,002
1,181
1,141
1,131
1,125
838
Operating Margin (%)
15.17
15.28
18.87
19.56
18.21
17.09
17.84
17.24
14.09
15.18
15.72
17.03
15.58
20.19
Depreciation Expense
28
32
33
36
39
42
45
46
47
49
50
55
57
43
Net Income, GAAP
71
78
99
104
119
109
115
106
104
128
148
149
137
97
Effective Tax Rate (%)
30.95
30.85
30.88
31.52
24.04
26.37
26.11
26.27
24.9
26.34
26.13
28.04
26.89
27
Profit Margin (%)
9.99
9.96
12.45
12.69
13.45
12.24
13.13
12.47
10.36
10.87
12.98
13.22
12.2
11.62
Working Capital
292
293
294
365
465
539
602
713
661
775
890
718
727
759
LT Debt
- -
- -
- -
- -
- -
- -
4
13
12
11
12
16
14
- -
Total Equity
593
601
623
727
843
948
1,066
1,167
1,116
1,239
1,384
1,284
1,323
1,350
Return on Invested Capital (%)
13.44
13.91
16.82
16.12
15.56
12.47
11.39
9.62
9.18
11.02
9.94
10.25
9.7
9.32
Return on Capital (%)
12.83
12.93
15.78
14.89
14.8
11.88
11.07
9.27
8.82
10.83
11.28
11
10.46
7.49
Return on Common Equity (%)
13.26
13.49
16.67
15.92
15.66
12.52
11.73
9.81
9.38
11.24
11.61
11.49
10.82
7.53

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
3
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
14
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
60
59
Market Capitalization
1,846
1,995
1,930

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
864
857
Cash, Cash Equivalents & STI
- -
376
353
Accounts Receivable, Net
- -
200
237
Inventories
- -
252
248
Total Current Liabilities
- -
136
98
Payables & Accruals
- -
64
97
ST Debt
- -
3
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.11%
2.83%
3.03%
Free Cash Flow
41.48%
71.12%
72.87%
Net Income, GAAP
3.83%
5.9%
-8.1%
Sales/Revenue/Turnover
3.78%
6.13%
-0.48%
Total Cash Common Dividend
460.26%
939.37%
2,011.42%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
277
283
285
285
1,131
2025
285
273
- -
285
1,125
2026
280
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.55
0.61
0.61
0.58
2.35
2025
0.56
0.49
- -
0.6
2.25
2026
0.53
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.02
0.02
0.04
0.1
2025
2.16
0.04
- -
0.04
2.29
2026
0.04
- -
- -
- -
- -

Company Description

MCPAPIChat
CEO
David A. Johns
Full Time Employees
2,900
Sector
Consumer Cyclical
Industry
Packaging & Containers
Address
100 Saulteaux Crescent Winnipeg MB Canada R3J 3T3
IPO Date
Apr 18, 2012
Website
winpak.com
Similar Companies
Toyo Seikan Group Holdings, Ltd. (5901.T)
Ohmura Shigyo Co.,Ltd. (3953.T)
Vidrala, S.A. (VID.MC)
Aeroflex Neu Limited (AERONEU.NS)
Nihon Seikan k.k. (5905.T)
Multibax Public Company Limited (MBAX.BK)
Business
Winpak Ltd. manufactures and distributes high-quality flexible and rigid packaging materials along with related packaging machines primarily for perishable foods, beverages and healthcare applications; its product portfolio encompasses modified atmosphere packaging films for fresh and processed meats, poultry and cheese; specialty films for converting applications including printing, laminating and bag making; biaxially oriented nylon films for food, industrial and other uses; rigid containers such as portion control, single-serve, custom and retort trays for food, pet food, beverage, dairy, industrial and healthcare markets; flexible lidding in die-cut, daisy chain and rollstock formats for similar applications; specialized printed packaging for pharmaceutical, healthcare, nutraceutical, cosmetic and personal care sectors; and horizontal fill/seal machines for preformed containers plus vertical form/fill/seal pouch machines for pumpable liquids, semi-liquids and dry products. The company operates through three segments including flexible packaging, rigid packaging and flexible lidding, and packaging machinery; it serves food and beverage, dairy, protein, pet food and healthcare markets with production facilities across Canada, the United States and Mexico. Founded in 1975 and headquartered in Winnipeg, Manitoba, Canada, Winpak Ltd. functions as a subsidiary of Wihuri International Oy. In recent developments, the company completes a multi-year, over $100 million expansion of its Winnipeg modified atmosphere packaging facility in 2025 to boost capacity for recycle-ready products and projects sales volume growth of 5 to 7 percent amid focus on pet food, in-mold-label, dairy and healthcare markets; it secures SBTi approval for near-term science-based emissions reduction targets and publishes its 2025 Sustainability Report highlighting progress on GHG emissions, energy and waste goals; launches Medform DT, a next-generation forming film for healthcare packaging, and the Winspeed portfolio for pharmaceutical supply chain agility; raises its quarterly dividend to 5 Canadian cents per share from 3 cents and pays a $3.00 Canadian cents special dividend in January 2025; fulfills and renews normal course issuer bid programs repurchasing millions of shares; and forecasts 2025 capital expenditures of $80 to $90 million while evaluating acquisitions in medical and pharmaceutical applications.